Moderator: Dan O'Connell, Managing Partner, NeuroVentures Capital
Neuroregeneration and Stem Cells:
Deborah Eppstein, President and CEO, Q Therapeutics
Andres Haegerstrand, Chief Scientific Officer, NeuroNova
Ad Statistics
Times Displayed: 40894
Times Visited: 1138 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Jonathan Kil, President and CEO, Sound Pharmaceuticals
Martin McGlynn, President and CEO, StemCells, Inc.
Session Chair: Frank Eeckman, NeuroInsights, NIO
NeuroVaccines, The Use of Vaccines in Neurology and Psychiatry:
Raafat Fahim, President and CEO, Nabi
Mark Schwartz, President and CEO, Bayhill Therapeutics
Walter Schmidt, CEO, Affiris
Session Chair: Roger Quy, General Partner, Technology Partners
Traumatic Injury: Stroke, Traumatic Brain Injury, and Spinal Cord Injury:
Martin Dieck, President and CEO, Nfocus Neuromedical
Shawn Lunney, CEO, Neurolutions
Vincent Simmon, President and CEO, Xytis
Michael Singer, CEO, BrainScope
Session Chair: Teo Forcht Dagi, Partner, HLM Venture Partners
Neuroscience Translation, Tech Transfer and Collaboration Opportunities:
Jamie Driscoll, Chief of Research Services, NIMH
Jill Heemskerk, Acting Director, Office of Translational Research, NINDS
Joe Pancrazio, Program Director, Extramural, Repair & Plasticity Cluster,
NINDS Session Chair: Melissa Maderia, Technology Transfer Specialist, NINDS
And that's just for starters.
Back to HCB News
